糖尿病多器官葡萄糖代谢改变:全身18F-FDG PET/CT研究
本研究利用全身18F-FDG PET/CT比较2型糖尿病患者与健康对照的多器官葡萄糖摄取模式,并探索其与脑体积等临床变量的关联。结果显示糖尿病患者脑、左心室心肌和颅骨SULmean显著降低,皮下脂肪组织SULmean升高,多变量调整后差异仍显著。脑体积与多器官SUL值呈中度正相关,糖尿病病程与脑及颅骨SULmean负相关。
要点
- 2型糖尿病患者脑、左心室心肌和颅骨葡萄糖代谢减低,皮下脂肪组织代谢增高。
- 脑体积与多器官SUL值呈中度正相关,糖尿病病程与脑及颅骨SULmean负相关。
- 全身PET/CT多器官代谢参数可能作为糖尿病并发症的影像生物标志物。
核心结论
- 2型糖尿病以高能量需求器官选择性葡萄糖代谢减低和脂肪组织代偿性激活为特征。
- 脑体积和病程与多器官葡萄糖代谢的独立关联提示全身PET/CT潜在影像生物标志物价值。
研究设计与样本
- 本研究为比较性研究,纳入2型糖尿病患者与健康对照,采用全身18F-FDG PET/CT定量多器官葡萄糖代谢。
主要发现
- 与对照组相比,糖尿病患者脑SULmean降低15.3%(P < 0.001),左心室心肌降低12.7%(P < 0.001),颅骨降低9.8%(P = 0.003)。
- 糖尿病患者皮下脂肪组织SULmean升高18.2%(P = 0.004),多变量调整后差异仍显著。
- 脑体积与多器官SUL值呈中度正相关(r = 0.44–0.63,P < 0.01),调整后关联仍显著。
- 糖尿病病程与脑和颅骨SULmean呈负相关(r = − 0.33 至 − 0.46,P < 0.05)。
临床怎么用
- 全身18F-FDG PET/CT多器官SULmean定量可用于评估2型糖尿病系统性代谢改变。
- 脑体积和糖尿病病程与器官葡萄糖代谢的关联或有助于识别糖尿病并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes mellitus (DM) is associated with systemic metabolic disturbances across multiple organs. Total-body 18F-fluorodeoxyglucose (F-FDG) PET/CT enables simultaneous quantification of glucose metabolism in numerous organs. This study aimed to characterize multi-organ 18F-FDG uptake patterns in type 2 DM patients compared with healthy controls and to explore associations with clinical variables including brain volume. RESULTS: Compared with controls, DM patients exhibited significantly lower SULmean in brain (− 15.3%, P < 0.001), left ventricular myocardium (− 12.7%, P < 0.001), and skull (− 9.8%, P = 0.003), and higher SULmean in subcutaneous adipose tissue (+ 18.2%, P = 0.004). Differences remained significant after multivariable adjustment. Brain volume showed moderate positive correlations with SUL values across multiple organs (r = 0.44–0.63, P < 0.01), and these associations remained significant after adjustment. DM duration negatively correlated with brain and skull SULmean (r = − 0.33 to − 0.46, P < 0.05). CONCLUSIONS: Type 2 DM is characterized by selective glucose hypometabolism in high-energy-demand organs and compensatory adipose activation. Independent associations with brain volume and disease duration suggest potential imaging biomarkers for diabetic complications using total-body PET/CT.
引用
- Wang M, Sun L, Wu Y, et al. Multi-organ glucose metabolism alterations in diabetes mellitus: a total-body 18F-FDG PET/CT study. EJNMMI Res. 2026. PMID: 41927952. doi:10.1186/s13550-026-01418-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。